Chargement en cours...
Inhibition of REV‐ERBs stimulates microglial amyloid‐beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer’s disease
A promising new therapeutic target for the treatment of Alzheimer's disease (AD) is the circadian system. Although patients with AD are known to have abnormal circadian rhythms and suffer sleep disturbances, the role of the molecular clock in regulating amyloid‐beta (Aβ) pathology is still poor...
Enregistré dans:
| Publié dans: | Aging Cell |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996949/ https://ncbi.nlm.nih.gov/pubmed/31800167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acel.13078 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|